Oral Dosage Form New Animal Drugs; Lufenuron Tablets
other · Food and Drug Administration · Rule · Published 1998-10-02 · Effective 1998-10-02 · 63 FR 52968
Document
Document number
98-26423
Federal Register citation
63 FR 52968
CFR reference
21 CFR 520
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-10-02
Effective date
1998-10-02
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for revising the specifications and conditions of use of lufenuron tablets for dogs and cats for control of flea populations.